Rotavirus Vaccine, Live, Oral, Pentavalent
Generic Name: rotavirus vaccine, live, oral, pentavalent
Brand Names:
Rotateq
Dosage form: SOLUTION. Route: ORAL. Active ingredients: HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN (2200000 [iU]/2mL); HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN (2800000 [iU]/2mL); HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN (2200000 [iU]/2mL); HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN (2000000 [iU]/2mL); HUMAN ROTAVIRUS A TYPE G6P1A(8) STRAIN WI79 LIVE ANTIGEN (2300000 [iU]/2mL). Category: BLA.
Overview
Dosage form: SOLUTION. Route: ORAL. Active ingredients: HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN (2200000 [iU]/2mL); HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN (2800000 [iU]/2mL); HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN (2200000 [iU]/2mL); HUMAN ROTAVIRUS A TYPE G4P7(5) STRAIN BRB LIVE ANTIGEN (2000000 [iU]/2mL); HUMAN ROTAVIRUS A TYPE G6P1A(8) STRAIN WI79 LIVE ANTIGEN (2300000 [iU]/2mL). Category: BLA.
Dosage
Available as solution for oral use.
Related Medications
Carya Illinoinensis Pollen And Carya Ovata Pollen
carya illinoinensis pollen and carya ovata pollen
Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: CARYA ILLINOINENSIS POLLEN (.05 g/mL); CARYA OVATA POLLEN (.05 g/mL). Category: BLA.
Inavolisib
inavolisib
Kinase Inhibitor [EPC]
11 DESCRIPTION ITOVEBI contains inavolisib, a kinase inhibitor. The chemical name of inavolisib is (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide. Inavolisib is a white to off-white, greyish pink, greyish orange, or greyish yellow powder or powder with lumps. Inavolisib demonstrates pH-dependent aqueous solubility; the greatest solubility is at low pH, and solubility decreases with increasing pH.
Menthol 11%, Camphor 11% Ointment
menthol 11%, camphor 11% ointment
PURPOSE Topical analgesic
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.